Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease
By: [prepared by Alan M. Garber ... et al.].
Contributors: Garber, Alan M.; United States. Congress. Office of Technology Assessment.
Series: Background paper / Office of Technology Assessment; Background paper (United States. Congress. Office of Technology Assessment).
Publisher: Office of Technology Assessment; For sale by the Supt. of Docs., U.S. G.P.O.
Published: 1992
Place of publication: Washington, DC
Language: eng
Number of pages: 34
Subjects: Gaucher's disease -- Treatment -- United States.; Orphan drugs -- United States.; Pharmaceutical policy -- United States.
Notes: Includes bibliographical references (p. 29-34).
"October 1992"--Cover p. 4.
S/N052-003-013096 (GPO).
"OTA-BP-H-104"--Cover p. 4.